August 7, 2020
What I provide is called a ‘warning” which can be a deduction, a perception that is a product of reasoning yet, a hypothesis whose validity can only be confirmed once it has happened
Pre-open indications: 6 BUYs and 4 SELLs
What I provide is an intelligence daily. RMi outlines the potential prelude to the daily dosage of facts and objectivity! Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors!
My gift to you, I've kept RMi subscription FREE during these COVID-19 and volatile times!
July 8, 2020
BLFS' underwriters' option included an additional 776,250 shares
The gross proceeds from the offering to BLFS, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $86 million.
August 7, 2020
The question continues, are we pre-booked on the roller-coaster?
Pre-open indication results: 7 HITs and 3 MISS
Week in review …
An “intelligence newspaper” for smart investing in the RegMed, gene and cell therapy sector. I say today what others won't, so you can do what others can't; I put into context what is relevant for investors
Subscription is coming, my gift to you however, I've kept RMi subscription FREE during these COVID-19 and volatile times!
July 8, 2020
BLFS' underwriters' option included an additional 776,250 shares The gross proceeds from the offering to BLFS, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $86 million.
July 2, 2020
MDXG opened UP +0.08 at $5.40 Under the Securities Purchase Agreement, MDXG is issuing shares of a newly created Series B Convertible Preferred Stock for an aggregate purchase price of $100,000,000 with $90,000,000 being made by an entity controlled by EW Healthcare Partners and $10,000,000.
June 26, 2020
EDIT closed down -$2.49 (-7.93%) to $28.92 at the market close of the offering close EDIT had upped the 4 million share offering to 6 million, then sold 6.9 million shares which includes the greenshoe of 900 K shares Gross proceeds were $215.6 million
© 2020 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
